Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 25 min ago
PreprintCC BY-NC-NDmedRxiv

Inflammatory protein profiling shows limited ability to distinguish sepsis from sepsis mimics

1 more authors
  1. 1Department of Emergency and Critical Care Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan; Institute of Nano-Life-Systems, Institutes of

Abstract

Sepsis mimics resemble sepsis clinically but may require different treatments. We evaluated whether inflammatory protein profiles could distinguish these conditions in a retrospective case-control study using 4 prospective Japanese cohorts. The study included 34 adults with sepsis and 46 with sepsis mimics. We measured 92 proteins using Olink, assessed between-group differences with false discovery rate (FDR) adjustment, and evaluated 3 prediction models using repeated nested cross-validation. No protein met the FDR threshold; the lowest FDR-adjusted P value was 0.345. The primary elastic-net model had an area under the receiver operating characteristic curve of 0.442 (95% confidence interval, 0.315-0.574), based on cross-validation predictions averaged for each participant. Random forest and gradient boosting also showed no clear evidence of discrimination above chance. Confidence intervals included chance performance in both the all-serum and quality-control-Pass sensitivity analyses. In this cohort, a single measurement of an inflammation-focused protein panel showed limited discrimination between sepsis and sepsis mimics. Integration with clinical information and longitudinal measurements warrants further investigation.

Related

  1. Acceptance and Perceived Control Distinguish Health Outcomes Across Immune-Mediated Inflammatory Diseases.
    Tessa S Folkertsma, Reinhard Bos, Sjaak Bloem +3
    Journal of multidisciplinary healthcarePeer-reviewedCC BY-NCFull textPsychiatry & mental healthEurope PMC
  2. Multidimensional Inflammatory Biomarker Profiling in COPD: A Latent Inflammatory Construct Associated with Disease Severity and Exacerbation Burden
    Oana Maria Catana, Ramona Cioboata, Denisa Maria Mitroi +3
    Diagnostics (Basel, Switzerland)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Clinical Interpretation of Repeated Isolation of Leclercia adecarboxylata from Sputum Specimens in an Elderly Patient with Limited Systemic Inflammatory Response: A Case Report.
    Pengfei Zhang, Lili Wei, Yaozhi Qi +1
    Infection and drug resistancePeer-reviewedCC BY-NCFull textEndocrinology & metabolismEurope PMC
  4. Blood Cytokine Profiling Reveals Distinct Inflammatory Signatures in Phenotypes A and B of Polyendocrine Metabolic Ovarian Syndrome (PMOS; formerly PCOS).
    L. P. Patra, B. S. Johnson, K. P. Jayakrishnan +2
    medRxivPreprintAll rights reservedFull textEndocrinology & metabolismmedRxiv
  5. Integrated Profiling of TNF Superfamily Ligands and Lung Inflammatory Markers in Tuberculosis-Type 2 Diabetes Mellitus Comorbidity
    Nandita Ganesh, Rajesh Kumar Radhakrishnan, Fathima Sumaira +6
    Medical sciences (Basel, Switzerland)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
BibTeX
@misc{kasugai2026inflammatory,
  title = {{Inflammatory protein profiling shows limited ability to distinguish sepsis from sepsis mimics}},
  author = {D. Kasugai and H. Onizuka and A. Numaguchi and T. Yamamoto and N. Kato and R. Sumiyoshi and S. Fukui and T. Koga and A. Kawakami and W. Fujii and Y. Kawahito and S. Maruyama and T. Shimamura},
  howpublished = {medRxiv},
  year = {2026},
  month = oct,
  doi = {10.64898/2026.10.10.26365202},
  url = {https://www.medrxiv.org/content/10.64898/2026.10.10.26365202v1},
  note = {CC BY-NC-ND},
}
RIS
TY  - UNPB
TI  - Inflammatory protein profiling shows limited ability to distinguish sepsis from sepsis mimics
AU  - D. Kasugai
AU  - H. Onizuka
AU  - A. Numaguchi
AU  - T. Yamamoto
AU  - N. Kato
AU  - R. Sumiyoshi
AU  - S. Fukui
AU  - T. Koga
AU  - A. Kawakami
AU  - W. Fujii
AU  - Y. Kawahito
AU  - S. Maruyama
AU  - T. Shimamura
PY  - 2026
DA  - 2026/10/10
PB  - medRxiv
DO  - 10.64898/2026.10.10.26365202
UR  - https://www.medrxiv.org/content/10.64898/2026.10.10.26365202v1
AB  - Sepsis mimics resemble sepsis clinically but may require different treatments. We evaluated whether inflammatory protein profiles could distinguish these conditions in a retrospective case-control study using 4 prospective Japanese cohorts. The study included 34 adults with sepsis and 46 with sepsis mimics. We measured 92 proteins using Olink, assessed between-group differences with false discovery rate (FDR) adjustment, and evaluated 3 prediction models using repeated nested cross-validation. No protein met the FDR threshold; the lowest FDR-adjusted P value was 0.345. The primary elastic-net model had an area under the receiver operating characteristic curve of 0.442 (95% confidence interval, 0.315-0.574), based on cross-validation predictions averaged for each participant. Random forest and gradient boosting also showed no clear evidence of discrimination above chance. Confidence intervals included chance performance in both the all-serum and quality-control-Pass sensitivity analyses. In this cohort, a single measurement of an inflammation-focused protein panel showed limited discrimination between sepsis and sepsis mimics. Integration with clinical information and longitudinal measurements warrants further investigation.
ER  -